Bausch Health Companies Inc. (TSX:BHC)

Canada · Delayed Price · Currency is CAD

7.89

+0.08 (1.02%)

At close: Feb 2, 2026

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Salix Revenue	2.52B	2.33B
International Rx Revenue	1.11B	1.11B
Solta Medical Revenue	519.00M	440.00M
Diversified Products Revenue	910.00M	950.00M
Bausch + Lomb Revenue	4.98B	4.79B
Revenue (Other)	-755.58M	-
Revenue (Total)	9.27B	9.63B

EBIT

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Salix Segment Profit	1.86B	1.60B
International Rx Segment Profit	351.00M	376.00M
Solta Medical Segment Profit	250.00M	213.00M
Diversified Products Segment Profit	605.00M	626.00M
Bausch + Lomb Segment Profit	1.04B	1.11B
Operating Income (Total)	1.72B	1.55B

Updated Sep 30, 2025. Data Source: Fiscal.ai.